SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000926617-22-000018
Filing Date
2022-04-29
Accepted
2022-04-29 17:11:55
Documents
3
Period of Report
2022-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A awh-20220429xdef14a.htm DEF 14A 1135222
2 GRAPHIC awh-20220429xdef14ag001.jpg GRAPHIC 74448
3 GRAPHIC awh-20220429xdef14ag002.jpg GRAPHIC 77584
  Complete submission text file 0000926617-22-000018.txt   1346225
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34810 | Film No.: 22877373
SIC: 2835 In Vitro & In Vivo Diagnostic Substances